Any attempt to explain the term "modern biotechnology" and to distinguish i
t from classical biotechnology soon reveals that the boundary is anything b
ut distinct and frequently disappears in a terminological fog. Things only
become easy when modern biotechnology can be defined as using the methods a
nd processes of genetic engineering. This is indeed often the case, but not
always. Modern biotechnology embracer advances in process engineering as w
ell as new developments in equipment; it depends on monoclonal antibodies a
nd new cell culture techniques, it benefits from advances in embryonal tran
sfer in the animal kingdom and also from cloning; it is taking over large a
reas of environmental engineering. This list could be continued. Processes
of classical biotechnology are always involved in the production of a moder
n biotechnological product. It is ultimately irrelevant to the engineer whe
ther a fermenter contains genetically engineering microorganisms or not; or
to the farmer whether the potatoes he grows are genetically modified or no
t. There can be no modern biotechnology without classical biotechnology - a
nd the reverse will soon also be true.